MedTrace Logo

The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora

NCT02240615 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-02-12

No results posted yet for this study

Summary

Prospective, open label, multi-center, non-randomized study designed to collect initial clinical data related to the safety and clinical performance of the Sinopsys Lacrimal Stent for use during repair of the lacrimal system in patients with functional or obstructive epiphora.

Conditions

  • Epiphora

Interventions

DEVICE

Sinopsys Lacrimal Stent

Procedural insertion of the Sinopsys Lacrimal Stent in patients with epiphora

Sponsors & Collaborators

  • Sinopsys Surgical

    lead INDUSTRY

Principal Investigators

  • Harry Ross, MD · Sinopsys Surgical Inc.

  • Teena Augostino · Sinopsys Surgical Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240615 on ClinicalTrials.gov